Significance of measurable residual disease in adults with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

被引：7

作者：

Rodriguez-Arboli, Eduardo ^{[1
,2
]}

Orvain, Corentin ^{[1
]}

Othus, Megan ^{[3
]}

Walter, Roland B. ^{[1
,4
,5
,6
]}

机构：

[1] Fred Hutchinson Canc Ctr, Clin Res Div, Seattle, WA 98109 USA

[2] Univ Seville, Inst Biomedicina Sevilla IBIS, Hosp Univ Virgen del Rocio, Dept Hematol,CSIC,CIBERONC, Seville, Spain

[3] Fred Hutchinson Canc Ctr, Publ Hlth Sci Div, Seattle, WA USA

[4] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA

[5] Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA

[6] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA

来源：

BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / 11期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1038/s41409-022-01794-4

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：1732 / 1734

页数：3

共 11 条

[1] Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis [J].

Buckley, Sarah A. ;

Wood, Brent L. ;

Othus, Megan ;

Hourigan, Christopher S. ;

Ustun, Celalettin ;

Linden, Michael A. ;

DeFor, Todd E. ;

Malagola, Michele ;

Anthias, Chloe ;

Valkova, Veronika ;

Kanakry, Christopher G. ;

Gruhn, Bernd ;

Buccisano, Francesco ;

Devine, Beth ;

Walter, Roland B. .

HAEMATOLOGICA, 2017, 102 (05) :865-873

[2] Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel [J].

Doehner, Hartmut ;

Estey, Elihu ;

Grimwade, David ;

Amadori, Sergio ;

Appelbaum, Frederick R. ;

Buechner, Thomas ;

Dombret, Herve ;

Ebert, Benjamin L. ;

Fenaux, Pierre ;

Larson, Richard A. ;

Levine, Ross L. ;

Lo-Coco, Francesco ;

Naoe, Tomoki ;

Niederwieser, Dietger ;

Ossenkoppele, Gert J. ;

Sanz, Miguel ;

Sierra, Jorge ;

Tallman, Martin S. ;

Tien, Hwei-Fang ;

Wei, Andrew H. ;

Lowenberg, Bob ;

Bloomfield, Clara D. .

BLOOD, 2017, 129 (04) :424-447

[3] Measurable residual disease for secondary acute myeloid leukemia prior to allogeneic hematopoietic cell transplantation: does it make a difference? [J].

El Chaer, Firas ;

Ballen, Karen K. .

BONE MARROW TRANSPLANTATION, 2022, 57 (10) :1473-1474

[4] Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials [J].

Grimwade, David ;

Hills, Robert K. ;

Moorman, Anthony V. ;

Walker, Helen ;

Chatters, Stephen ;

Goldstone, Anthony H. ;

Wheatley, Keith ;

Harrison, Christine J. ;

Burnett, Alan K. .

BLOOD, 2010, 116 (03) :354-365

[5] 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party [J].

Heuser, Michael ;

Freeman, Sylvie D. ;

Ossenkoppele, Gert J. ;

Buccisano, Francesco ;

Hourigan, Christopher S. ;

Ngai, Lok Lam ;

Tettero, Jesse M. ;

Bachas, Costa ;

Baer, Constance ;

Bene, Marie-Christine ;

Bucklein, Veit ;

Czyz, Anna ;

Denys, Barbara ;

Dillon, Richard ;

Feuring-Buske, Michaela ;

Guzman, Monica L. ;

Haferlach, Torsten ;

Han, Lina ;

Herzig, Julia K. ;

Jorgensen, Jeffrey L. ;

Kern, Wolfgang ;

Konopleva, Marina Y. ;

Lacombe, Francis ;

Libura, Marta ;

Majchrzak, Agata ;

Maurillo, Luca ;

Ofran, Yishai ;

Philippe, Jan ;

Plesa, Adriana ;

Preudhomme, Claude ;

Ravandi, Farhad ;

Roumier, Christophe ;

Subklewe, Marion ;

Thol, Felicitas ;

van de Loosdrecht, Arjan A. ;

van der Reijden, Bert A. ;

Venditti, Adriano ;

Wierzbowska, Agnieszka ;

Valk, Peter J. M. ;

Wood, Brent L. ;

Walter, Roland B. ;

Thiede, Christian ;

Dohner, Konstanze ;

Roboz, Gail J. ;

Cloos, Jacqueline .

BLOOD, 2021, 138 (26) :2753-2767

[6] Measurable residual disease testing in acute myeloid leukaemia [J].

Hourigan, C. S. ;

Gale, R. P. ;

Gormley, N. J. ;

Ossenkoppele, G. J. ;

Walter, R. B. .

LEUKEMIA, 2017, 31 (07) :1482-1490

[7] Acute myeloid leukemia ontogeny is defined by distinct somatic mutations [J].

Lindsley, R. Coleman ;

Mar, Brenton G. ;

Mazzola, Emanuele ;

Grauman, Peter V. ;

Shareef, Sarah ;

Allen, Steven L. ;

Pigneux, Arnaud ;

Wetzler, Meir ;

Stuart, Robert K. ;

Erba, Harry P. ;

Damon, Lloyd E. ;

Powel, Bayard L. ;

Lindeman, Neal ;

Steensma, David P. ;

Wadleigh, Martha ;

DeAngelo, Daniel J. ;

Neuberg, Donna ;

Stone, Richard M. ;

Ebert, Benjamin L. .

BLOOD, 2015, 125 (09) :1367-1376

[8] Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT) [J].

Maffini, Enrico ;

Labopin, Myriam ;

Beelen, Dietrich Wilhelm ;

Kroeger, Nicolaus ;

Arat, Mutlu ;

Wilson, Keith M. O. ;

Bay, Jacques-Olivier ;

Ganser, Arnold ;

Martin, Hans ;

Passweg, Jakob ;

Kottaridis, Panagiotis D. ;

Yakoub-Agha, Ibrahim ;

Porras, Rocio Parody ;

Wagner, Eva Maria ;

Esteve, Jordi ;

Lanza, Francesco ;

Nagler, Arnon ;

Mohty, Mohamad .

BONE MARROW TRANSPLANTATION, 2022, 57 (10) :1556-1563

[9]

Orvain C, 2022, HAEMATOLOGICA

[10] Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML [J].

Paras, Gabrielle ;

Morsink, Linde M. ;

Othus, Megan ;

Milano, Filippo ;

Sandmaier, Brenda M. ;

Zarling, Lucas C. ;

Palmieri, Raffaele ;

Schoch, Gary ;

Davis, Chris ;

Bleakley, Marie ;

Flowers, Mary E. D. ;

Deeg, H. Joachim ;

Appelbaum, Frederick R. ;

Storb, Rainer ;

Walter, Roland B. .

BLOOD, 2022, 139 (11) :1694-1706

← 1 2 →